HEADER OXIDOREDUCTASE 30-DEC-15 5HA7 TITLE HUMAN ALDOSE REDUCTASE IN COMPLEX WITH NADP+ AND WY14643 IN SPACE TITLE 2 GROUP P212121 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: AR,ALDEHYDE REDUCTASE,ALDO-KETO REDUCTASE FAMILY 1 MEMBER COMPND 5 B1; COMPND 6 EC: 1.1.1.21; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1B1, ALDR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS ALPHA/BETA BARREL, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.R.SAWAYA,D.CASCIO,G.K.BALENDIRAN REVDAT 3 22-NOV-17 5HA7 1 REMARK REVDAT 2 26-OCT-16 5HA7 1 JRNL REVDAT 1 28-SEP-16 5HA7 0 JRNL AUTH M.R.SAWAYA,M.VERMA,V.BALENDIRAN,N.P.RATH,D.CASCIO, JRNL AUTH 2 G.K.BALENDIRAN JRNL TITL CHARACTERIZATION OF WY 14,643 AND ITS COMPLEX WITH ALDOSE JRNL TITL 2 REDUCTASE. JRNL REF SCI REP V. 6 34394 2016 JRNL REFN ESSN 2045-2322 JRNL PMID 27721416 JRNL DOI 10.1038/SREP34394 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.18 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 85620 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.168 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4556 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5917 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.3150 REMARK 3 BIN FREE R VALUE SET COUNT : 337 REMARK 3 BIN FREE R VALUE : 0.2990 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5050 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 178 REMARK 3 SOLVENT ATOMS : 566 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.04000 REMARK 3 B22 (A**2) : -2.05000 REMARK 3 B33 (A**2) : 3.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.087 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.086 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.067 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.175 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.976 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.968 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5411 ; 0.014 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 5130 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7384 ; 1.692 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11860 ; 0.991 ; 2.987 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 646 ; 5.706 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 235 ;40.578 ;24.809 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 933 ;11.854 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ; 8.494 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 816 ; 0.104 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5956 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1190 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2542 ; 2.034 ; 2.134 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2541 ; 2.031 ; 2.134 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3178 ; 2.560 ; 3.589 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 0 A 320 REMARK 3 ORIGIN FOR THE GROUP (A): 22.6111 -0.3574 4.1858 REMARK 3 T TENSOR REMARK 3 T11: 0.0398 T22: 0.0560 REMARK 3 T33: 0.0082 T12: -0.0009 REMARK 3 T13: 0.0013 T23: 0.0073 REMARK 3 L TENSOR REMARK 3 L11: 0.4082 L22: 0.4323 REMARK 3 L33: 0.0716 L12: 0.0254 REMARK 3 L13: -0.1638 L23: -0.0245 REMARK 3 S TENSOR REMARK 3 S11: -0.0178 S12: -0.0513 S13: 0.0019 REMARK 3 S21: -0.0119 S22: 0.0239 S23: -0.0489 REMARK 3 S31: 0.0018 S32: 0.0045 S33: -0.0062 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 0 B 320 REMARK 3 ORIGIN FOR THE GROUP (A): -13.6443 0.3728 4.2168 REMARK 3 T TENSOR REMARK 3 T11: 0.0313 T22: 0.0488 REMARK 3 T33: 0.0239 T12: 0.0071 REMARK 3 T13: -0.0041 T23: -0.0101 REMARK 3 L TENSOR REMARK 3 L11: 0.4100 L22: 0.5753 REMARK 3 L33: 0.0908 L12: -0.0968 REMARK 3 L13: 0.1771 L23: 0.0139 REMARK 3 S TENSOR REMARK 3 S11: -0.0311 S12: -0.0594 S13: 0.0058 REMARK 3 S21: -0.0186 S22: 0.0355 S23: 0.0705 REMARK 3 S31: -0.0068 S32: -0.0081 S33: -0.0044 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : WITH TLS ADDED REMARK 4 REMARK 4 5HA7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-DEC-15. REMARK 100 THE DEPOSITION ID IS D_1000216747. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.14, AUTOPROC 1.0.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 85620 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.649 REMARK 200 RESOLUTION RANGE LOW (A) : 52.180 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.65 REMARK 200 COMPLETENESS FOR SHELL (%) : 61.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.45200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC 5.2.0019 REMARK 200 STARTING MODEL: 3Q65 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.71 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.04 M AMMONIUM SULFATE, 0.1M HEPES PH REMARK 280 7.5, 7% POLYETHYLENE GLYCOL 400, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.65300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.18500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.95850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.18500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.65300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.95850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL UNIT IS A MONOMER. THERE ARE TWO BIOLOGICAL REMARK 300 UNITS IN THE ASYMMETRIC UNIT (CHAIN A AND CHAIN B). REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 50 12.66 -140.05 REMARK 500 LEU A 190 80.96 -153.26 REMARK 500 ARG A 293 18.41 -140.24 REMARK 500 ASN B 50 16.89 -142.31 REMARK 500 LEU B 190 81.18 -152.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue WY1 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 406 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue WY1 B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 403 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 404 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 405 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 406 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3Q65 RELATED DB: PDB REMARK 900 3Q65 CONTAINS THE SAME PROTEIN BUT WITHOUT WY14643 INHIBITOR BOUND. DBREF 5HA7 A 0 315 UNP P15121 ALDR_HUMAN 1 316 DBREF 5HA7 B 0 315 UNP P15121 ALDR_HUMAN 1 316 SEQADV 5HA7 ILE A 4 UNP P15121 LEU 5 ENGINEERED MUTATION SEQADV 5HA7 ILE B 4 UNP P15121 LEU 5 ENGINEERED MUTATION SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 A 316 HIS GLU GLU PHE SEQRES 1 B 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 B 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 B 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 B 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 B 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 B 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 B 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 B 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 B 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS SEQRES 10 B 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 B 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 B 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 B 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 B 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 B 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 B 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 B 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 B 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 B 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 B 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 B 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 B 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 B 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 B 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 B 316 HIS GLU GLU PHE HET NAP A 401 48 HET WY1 A 402 21 HET SO4 A 403 5 HET SO4 A 404 5 HET SO4 A 405 5 HET SO4 A 406 5 HET NAP B 401 48 HET WY1 B 402 21 HET SO4 B 403 5 HET SO4 B 404 5 HET SO4 B 405 5 HET SO4 B 406 5 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM WY1 2-({4-CHLORO-6-[(2,3-DIMETHYLPHENYL)AMINO]PYRIMIDIN-2- HETNAM 2 WY1 YL}SULFANYL)ACETIC ACID HETNAM SO4 SULFATE ION HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 WY1 2(C14 H14 CL N3 O2 S) FORMUL 5 SO4 8(O4 S 2-) FORMUL 15 HOH *566(H2 O) HELIX 1 AA1 PRO A 23 GLY A 38 1 16 HELIX 2 AA2 ALA A 45 GLN A 49 5 5 HELIX 3 AA3 ASN A 50 GLU A 64 1 15 HELIX 4 AA4 LYS A 68 LEU A 72 5 5 HELIX 5 AA5 TRP A 79 HIS A 83 5 5 HELIX 6 AA6 GLU A 84 GLY A 86 5 3 HELIX 7 AA7 LEU A 87 LYS A 100 1 14 HELIX 8 AA8 ASN A 136 GLU A 150 1 15 HELIX 9 AA9 ASN A 162 ASN A 171 1 10 HELIX 10 AB1 GLN A 192 LYS A 202 1 11 HELIX 11 AB2 SER A 226 GLU A 229 5 4 HELIX 12 AB3 ASP A 230 HIS A 240 1 11 HELIX 13 AB4 THR A 243 GLN A 254 1 12 HELIX 14 AB5 THR A 265 LYS A 274 1 10 HELIX 15 AB6 SER A 281 SER A 290 1 10 HELIX 16 AB7 LEU A 300 THR A 304 5 5 HELIX 17 AB8 PRO B 23 GLY B 38 1 16 HELIX 18 AB9 ALA B 45 GLN B 49 5 5 HELIX 19 AC1 ASN B 50 GLU B 64 1 15 HELIX 20 AC2 LYS B 68 LEU B 72 5 5 HELIX 21 AC3 TRP B 79 HIS B 83 5 5 HELIX 22 AC4 GLU B 84 GLY B 86 5 3 HELIX 23 AC5 LEU B 87 LYS B 100 1 14 HELIX 24 AC6 ASN B 136 GLU B 150 1 15 HELIX 25 AC7 ASN B 162 ASN B 171 1 10 HELIX 26 AC8 GLN B 192 LYS B 202 1 11 HELIX 27 AC9 SER B 226 GLU B 229 5 4 HELIX 28 AD1 ASP B 230 HIS B 240 1 11 HELIX 29 AD2 THR B 243 GLN B 254 1 12 HELIX 30 AD3 THR B 265 LYS B 274 1 10 HELIX 31 AD4 SER B 281 SER B 290 1 10 HELIX 32 AD5 LEU B 300 THR B 304 5 5 SHEET 1 AA1 2 ARG A 3 LEU A 5 0 SHEET 2 AA1 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 AA2 8 LEU A 17 GLY A 18 0 SHEET 2 AA2 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 AA2 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 AA2 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 AA2 8 ILE A 156 SER A 159 1 O GLY A 157 N TYR A 107 SHEET 6 AA2 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 AA2 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 AA2 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SHEET 1 AA3 2 ARG B 3 LEU B 5 0 SHEET 2 AA3 2 LYS B 11 PRO B 13 -1 O MET B 12 N ILE B 4 SHEET 1 AA4 8 LEU B 17 GLY B 18 0 SHEET 2 AA4 8 HIS B 41 ASP B 43 1 O ASP B 43 N LEU B 17 SHEET 3 AA4 8 PHE B 73 LEU B 78 1 O VAL B 75 N ILE B 42 SHEET 4 AA4 8 LEU B 106 ILE B 109 1 O LEU B 108 N LEU B 78 SHEET 5 AA4 8 ILE B 156 SER B 159 1 O GLY B 157 N TYR B 107 SHEET 6 AA4 8 VAL B 181 GLU B 185 1 O VAL B 181 N ILE B 158 SHEET 7 AA4 8 VAL B 205 TYR B 209 1 O THR B 207 N ILE B 184 SHEET 8 AA4 8 VAL B 258 VAL B 259 1 O VAL B 258 N ALA B 208 SITE 1 AC1 35 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 35 ASP A 43 TYR A 48 HIS A 110 SER A 159 SITE 3 AC1 35 ASN A 160 GLN A 183 TYR A 209 SER A 210 SITE 4 AC1 35 PRO A 211 LEU A 212 GLY A 213 SER A 214 SITE 5 AC1 35 PRO A 215 ASP A 216 ALA A 245 ILE A 260 SITE 6 AC1 35 PRO A 261 LYS A 262 SER A 263 VAL A 264 SITE 7 AC1 35 THR A 265 ARG A 268 GLU A 271 ASN A 272 SITE 8 AC1 35 WY1 A 402 HOH A 516 HOH A 521 HOH A 540 SITE 9 AC1 35 HOH A 698 GLN B 26 HOH B 703 SITE 1 AC2 10 TRP A 20 VAL A 47 TYR A 48 HIS A 110 SITE 2 AC2 10 TRP A 111 PHE A 122 TRP A 219 NAP A 401 SITE 3 AC2 10 HOH A 631 HOH A 641 SITE 1 AC3 4 ARG A 63 HOH A 676 HOH A 694 HIS B 163 SITE 1 AC4 3 ALA A 1 SER A 2 ARG A 3 SITE 1 AC5 2 ARG A 3 LYS A 11 SITE 1 AC6 3 LYS A 239 SER A 281 GLN A 283 SITE 1 AC7 35 GLN A 26 HOH A 516 GLY B 18 THR B 19 SITE 2 AC7 35 TRP B 20 LYS B 21 ASP B 43 TYR B 48 SITE 3 AC7 35 HIS B 110 SER B 159 ASN B 160 GLN B 183 SITE 4 AC7 35 TYR B 209 SER B 210 PRO B 211 LEU B 212 SITE 5 AC7 35 GLY B 213 SER B 214 PRO B 215 ASP B 216 SITE 6 AC7 35 ALA B 245 ILE B 260 PRO B 261 LYS B 262 SITE 7 AC7 35 SER B 263 VAL B 264 THR B 265 ARG B 268 SITE 8 AC7 35 GLU B 271 ASN B 272 WY1 B 402 HOH B 524 SITE 9 AC7 35 HOH B 601 HOH B 680 HOH B 683 SITE 1 AC8 10 TRP B 20 VAL B 47 TYR B 48 HIS B 110 SITE 2 AC8 10 TRP B 111 PHE B 122 TRP B 219 NAP B 401 SITE 3 AC8 10 HOH B 609 HOH B 622 SITE 1 AC9 4 HIS A 163 ARG B 63 HOH B 679 HOH B 702 SITE 1 AD1 4 ALA B 1 SER B 2 ARG B 3 HOH B 705 SITE 1 AD2 2 ARG B 3 LYS B 11 SITE 1 AD3 4 LYS B 242 GLN B 246 LYS B 274 HOH B 597 CRYST1 83.306 85.917 104.370 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012004 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011639 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009581 0.00000 MASTER 358 0 12 32 20 0 32 6 0 0 0 50 END